This small molecule compound demonstrates exceptional ability to block nicotinamide N-methyltransferase enzyme activity, preventing NAD+ depletion while activating sirtuin pathways associated with healthy aging and metabolic optimization
Suggested Use Levels: .3-3% (Typically 1%)
Researchers examine how this growth hormone fragment affects fat cell function, lipid mobilization, glucose metabolism, and weight regulation in experimental systems focused on obesity, metabolic syndrome, and lipid disorders
Ipamorelin Known for its minimal side effects, Ipamorelin works well when combined with CJC-1295 to maximize results without increasing hunger
Body Composition Changes: More significant changes, such as a reduction in body fat or noticeable weight loss, typically occur over a period of 48 weeks
The process may include: Health Evaluation Your provider learns about your symptoms, lifestyle, and overall health